1 Min Read
Feb 15 (Reuters) - SciVision Biotech Inc:
* Says it got the third category of medical materials sales license from TFDA for its two products used for obstetrics and gynecology and urology
Source text in Chinese: goo.gl/m6hV83; goo.gl/o73pGa
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.